Literature DB >> 6223093

A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.

T Sakane, H Kotani, S Takada, Y Murakawa, Y Ueda.   

Abstract

The autologous mixed lymphocyte reaction (MLR) is thought to be part of a regulatory role of T cells on B cell function. OKT4+, but not OKT8+, cells can proliferate in response to autologous non-T cells. Moreover, the OKT4+ cell population activated early in the course of autologous MLR functioned as inducer cells for the differentiation of B cells, whereas later in the response, the activated OKT4+ cells were particularly enriched in suppressor cells. A part of the autologous MLR appears to be an important pathway for the activation of feedback suppression mechanisms among cells contained within the OKT4+ populations. Patients with systemic lupus erythematosus (SLE) were studied with regard to the following OKT4+ cell functions in vitro after activation in the autologous MLR: a) proliferative response, and b) helper and suppressor activities for differentiation of B cells. A marked reduction in the proliferative response of OKT4+ cells was observed in SLE patients. SLE OKT4+ cells activated in the autologous MLR could function as helper cells but could not exert any suppressor activity. This OKT4+ cell abnormality was present regardless of the disease activity, and occurred in the absence of autoantibodies including anti-T cell antibodies. Instead, SLE anti-T cell antibodies could preferentially eliminate cells bearing the OKT8+ phenotype characteristic of suppressor cells in populations of normal T cells. These results suggest that the defect in the suppressor circuits among OKT4+ cell populations is intrinsic to SLE lymphocytes and that the OKT8+ suppressor T cell defect is caused by antibodies produced by the B cells of SLE patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223093

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Impairment of autologous mixed lymphocyte reaction in the spleen and peripheral blood lymphocytes of patients with idiopathic portal hypertension.

Authors:  H Yamaue; H Tanimura; M Iwahashi; T Tsunoda; M Tani; M Tamai; M Inoue
Journal:  Gastroenterol Jpn       Date:  1990-04

Review 2.  Lymphocyte subpopulations.

Authors:  R J Powell; J S Jenkins
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

3.  Activation of OKT4 suppressor cells in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.

Authors:  K Oen; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  Defective autologous mixed lymphocyte reactivity in multiple sclerosis.

Authors:  R L Hirsch
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

5.  OKT4+ and OKT8+ T lymphocytes produce soluble factors that can modulate growth and differentiation of human B cells.

Authors:  T Sakane; Y Ueda; N Suzuki; Y Niwa; T Hoshino; T Tsunematsu
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

6.  Antibodies specific for measles virus envelope antigens and autoantibodies in patients with chronic active hepatitis.

Authors:  P V Shirodaria; S A McMillan; M E Callender; M Haire; E Fleming; J D Merrett; T T Fulton
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

Review 7.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

8.  Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.

Authors:  H Kotani; S Takada; Y Ueda; Y Murakawa; N Suzuki; T Sakane
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

9.  The influence of interferon-gamma, interleukin-2, prostaglandin E2, and cyclosporine on the polyclonal and anti-DNA antibody secretion in lymphocyte cultures derived from patients with systemic lupus erythematosus.

Authors:  H D Volk; N Sönnichsen; S Jahn; F Hiepe; E Apostoloff; R von Baehr; W Diezel
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

10.  The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.

Authors:  P S Mach; M Kharouby; F Lutcher; J L Olivier; N Bazely; M Dougados; B Amor
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.